98%
921
2 minutes
20
Background: There is little data about the prognostic value of mitral annular dilatation (MAD) in patients with symptomatic severe aortic regurgitation (AR) undergoing transcatheter aortic valve replacement (TAVR). This study aimed to assess the prognosis value of computed tomography (CT)-determined MAD in such patients.
Methods: Consecutive patients with symptomatic severe AR who underwent pre-TAVR CT between May 2014 and May 2023 were included in this study. The clinical endpoint was the composite outcome of all-cause death and heart-failure hospitalization. Mitral annular dimensions were systematically measured by CT. A receiver operating characteristic (ROC) curve analysis was performed to obtain an ideal body surface area standardized cut-off value for MAD. A Cox regression analysis was performed to examine the association between MAD and composite outcomes. The incremental prognostic value of MAD was evaluated by calculating the net reclassification improvement and the integrated discrimination improvement.
Results: Among the 281 patients (72.6±7.5 years, 33.1% female), 41 (14.6%) reached the clinical endpoint during a median follow-up period of 2.0 years. MAD was identified in 132 (47.0%) patients based on a ROC cut-off value of 71.3 mm/m. The multivariable Cox analysis, which included clinical and echocardiographic parameters, confirmed that MAD [hazard ratio (HR): 4.07; 95% confidence interval (CI): 1.85-8.99; P=0.001) was associated with the composite outcome. Importantly, MAD provided incremental prognostic value over clinical and echocardiographic characteristics [net reclassification improvement: 0.40 (95% CI: 0.21-0.54), P=0.01; integrated discrimination improvement: 0.06 (95% CI: 0.01-0.14), P=0.02].
Conclusions: MAD was an independent predictor of adverse outcomes after TAVR in patients with severe AR, and added incremental prognostic value to a baseline model composed of clinical and echocardiographic characteristics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847191 | PMC |
http://dx.doi.org/10.21037/qims-24-1608 | DOI Listing |
Cureus
August 2025
Internal Medicine, Jaber Al-Ahmad Hospital, Al Jahra, KWT.
Heart failure (HF) remains a global health challenge with high morbidity and mortality, necessitating reliable biomarkers for risk stratification. The platelet-to-lymphocyte ratio (PLR), an emerging inflammatory marker, has shown prognostic potential in cardiovascular diseases, but its utility in HF remains inconsistently reported. This systematic review synthesizes evidence on PLR's prognostic value in HF, focusing on mortality, hospitalization, and its role in multimarker models.
View Article and Find Full Text PDFJ Am Soc Echocardiogr
September 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Background And Aims: Light chain cardiac amyloidosis (AL-CA), wild-type-transthyretin cardiac amyloidosis (ATTRwt-CA) and hereditary type-transthyretin cardiac amyloidosis (ATTRv-CA) have distinct presentations, clinical courses, and prognosis. To identify differentiating echocardiographic features and their prognostic significance, we investigated a large cohort of patients with CA.
Methods: In this multi-site cohort study, CA diagnosis was verified according to guidelines.
JACC Adv
August 2025
Department of General Internal Medicine 3, Kawasaki Medical School, Kurashiki, Japan.
Background: Heart failure (HF) is a substantial public health concern associated with poor prognosis and limited tools for early prediction. Arterial stiffness contributes to the development of HF, particularly with a preserved ejection fraction. The cardio-ankle vascular index (CAVI) is a noninvasive, pressure-independent marker of arterial stiffness.
View Article and Find Full Text PDFInsights Imaging
August 2025
Department of Magnetic Resonance Imaging, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Objectives: To assess the left ventricular remodeling index (LVRI) for predicting ventricular tachyarrhythmia (VTA) in patients with dilated cardiomyopathy (DCM) with left ventricular ejection fraction (LVEF) < 35%.
Materials And Methods: In this retrospective single-center study, consecutive DCM patients with LVEF < 35% (n = 271) who underwent cardiac magnetic resonance (CMR) imaging were followed up. The study endpoint was VTA, including sudden cardiac death and major ventricular arrhythmias.
J Gastrointest Cancer
August 2025
Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Objective: This study aimed to assess the predictive value of CT-FFR on survival in patients with esophageal carcinoma (EC) after esophagectomy.
Methods: Five hundred and eighty patients with EC who had coronary computed tomography angiography (CCTA) and esophagectomy from January 2012 to September 2023 were included in this study. The lesion-specific fractional flow reserve (FFR) was derived from CCTA.